May 20, 2022 | Copay Accumulators
Surabhi Dangi-Garimella, PhD Co-pay accumulator and maximizer programs run by commercial health plans and pharmacy benefit managers (PBMs) have been designed to counter co-pay assistance programs floated by drug manufacturers. They prevent the co-pay assistance from...
May 17, 2022 | Featured, Health Insurance, Podcast
On this episode of the podcast, Terry and Bob discuss health access challenges facing patients with rare diseases on employer health plans. They point out new data on drug rebates showing no relationship between the size of rebates and drug price savings. And they...
May 16, 2022 | Featured, Letters Submitted
We appreciate the work of the Senate Committee on Health, Education, Labor, and Pensions (HELP) in reauthorizing the Food and Drug Administration’s (FDA) user fee programs for generic drugs (GDUFA). The improvements in GDUFA III will speed patient access to safe,...
May 13, 2022 | Featured, Health Policy
Surabhi Dangi-Garimella, Ph.D. Despite biosimilars being around for a while, utilization in the U.S. has not caught on. Several studies have shown the cost benefit of replacing originator or reference products with biosimilars; however, contracts between drug...
May 9, 2022 | Featured, Podcast
On this episode of the podcast, Terry and Bob discuss the latest medical research into ALS in conjunction with ALS Awareness Month. Dr. Sharon Hesterlee, the Chief Research Officer at the Muscular Dystrophy Association, joins the show to give the big picture on ALS...
May 6, 2022 | Featured, Podcast
On this episode of the podcast, Terry and Bob discuss health insurance plan benefit design and the critical role of nurse navigators who can help patients contend with the complicated American healthcare system. Have you ever felt overwhelmed or confused in your...
May 5, 2022 | Featured, Pharmacy Benefit Managers
Pharmacy Benefit Managers (PBMs) are the middlemen who work for insurance companies to determine what drugs are and aren’t covered on an insurance formulary. They are a player in the supply chain between the manufacturers who make the drug and the patients who need...
May 5, 2022 | Pharmacy Benefit Managers, Public Statement
WASHINGTON — Patients Rising Now Executive Director Terry Wilcox today released the following statement in response to the Senate Subcommittee on Consumer Protection, Product Safety, and Data Security hearing on pharmacy benefit managers: “Each player in the drug...
May 4, 2022 | Featured, Terry's Hot Take
Welcome to the May edition of Terry’s Hot Take, a monthly resource for lawmakers by the Executive Director of Patients Rising Now, on behalf of the 133 million Americans living with chronic disease. Always delivered on Taco Tuesday, the best day of the week! SAVE THE...
May 3, 2022 | Public Statement, QALY
WASHINGTON — Patients Rising Executive Director Terry Wilcox today released the following statement regarding the introduction of The Protecting Health Care for All Patients Act by Reps. Cathy McMorris Rodgers (WA-05), Jim Banks (IN-03) and Brad Wenstrup (OH-02). The...
